West Announces First Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
West Pharma (WST) Tops Q1 EPS by 2c; Boosts Lower-End of FY16 Outlook
April 28, 2016 9:38 AM EDTWest Pharma (NYSE: WST) reported Q1 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $362.1 million versus the consensus estimate of $355.86 million.
GUIDANCE:
West Pharma sees FY2016 EPS of $2.12-$2.25, versus prior guidance of... More



